KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $556.1 million.

  • Eli Lilly's Change in Acquisitions & Divestments rose 71899.85% to $556.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $887.6 million, marking a year-over-year increase of 15367.25%. This contributed to the annual value of $373.6 million for FY2024, which is 2647.12% down from last year.
  • Eli Lilly's Change in Acquisitions & Divestments amounted to $556.1 million in Q3 2025, which was up 71899.85% from $204.3 million recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Change in Acquisitions & Divestments registered a high of $753.4 million during Q4 2021, and its lowest value of $4.0 million during Q1 2021.
  • For the 5-year period, Eli Lilly's Change in Acquisitions & Divestments averaged around $150.3 million, with its median value being $83.1 million (2022).
  • In the last 5 years, Eli Lilly's Change in Acquisitions & Divestments crashed by 8913.04% in 2021 and then skyrocketed by 193500.0% in 2022.
  • Eli Lilly's Change in Acquisitions & Divestments (Quarter) stood at $753.4 million in 2021, then plummeted by 87.97% to $90.6 million in 2022, then crashed by 64.79% to $31.9 million in 2023, then surged by 74.29% to $55.6 million in 2024, then soared by 900.18% to $556.1 million in 2025.
  • Its Change in Acquisitions & Divestments was $556.1 million in Q3 2025, compared to $204.3 million in Q2 2025 and $71.6 million in Q1 2025.